लोड हो रहा है...
Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
OBJECTIVE: To compare 2‐year effectiveness and discontinuation of natalizumab (NTZ) versus fingolimod (FTY) and dimethyl fumarate (DMF) in the treatment of multiple sclerosis (MS). METHODS: Patients prescribed NTZ, FTY, or DMF at the Rocky Mountain MS Center at University of Colorado were identified...
में बचाया:
| में प्रकाशित: | Ann Clin Transl Neurol |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389745/ https://ncbi.nlm.nih.gov/pubmed/30847358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.700 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|